ÂÜÀòÂÒÂ×

Maxime Griffin currently serves as the Senior Director of Finance at Kedrion Biopharma, overseeing U.S. financial operations, including accounting, FP&A, treasury, and transactions, while managing a revenue portfolio of $1 billion. Previously, Maxime held the position of Director of Finance at KEDPLASMA, responsible for global plasma finance, and served as Director of Finance and Senior Finance Manager at BPL Plasma, where leadership included accounting, budgeting, and forecasting functions. Former roles include assistant controller and controller for IT/legal functions at Ingersoll Rand, financial analyst at Duke Energy, and senior audit consultant at Bank of America. Education includes a BS in Accounting from the University of Richmond and further studies at the University of Georgia's Terry College of Business.